Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novolytics

Novolytics
2002 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of bacteriophage-based therapeutics. The company is developing bacteriophage-based therapeutics for combating antibiotic resistant bacteria using nature's antidote.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Saint Thomas's Road
  • Chorley PR7 1HP
  • England, United Kingdom

Novolytics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novolytics‘s full profile, request access.

Request full access to PitchBook

Novolytics Executive Team (2)

Name Title Board
Seat
Contact
Info
Nick Housby Co-Founder, Chief Executive Officer & Board Member
Nicholas Mann Ph.D Co-Founder, Chief Scientific Officer & Director

Novolytics Board Members (1)

Name Representing Role Since Contact
Info
0000 000000 Novolytics Co-Founder, Chief Executive Officer & Board Member 000 0000